Published in Medical Letter on the CDC and FDA, November 1st, 2009
This recommendation followed an FDA Pre-Approval Inspection of UI Pharmaceutical's facilities and procedures and review of the product's manufacturing and testing procedures described in the client's New Drug Application. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA